Pharmaceutical

BridgeBio Oncology Therapeutics launches with $200m funding

BridgeBio Pharma has announced the launch of BridgeBio Oncology Therapeutics (BBOT), underpinned by $200m of private external capital.

May 5, 2024 - 00:00
BridgeBio Oncology Therapeutics launches with $200m funding
BridgeBio Pharma has announced the launch of BridgeBio Oncology Therapeutics (BBOT), underpinned by $200m of private external capital.
Read the original article

Tags:

Previous Article

NHS to provide Pfizer’s Voxelotor to treat sickle cell disease

Next Article

Optimisation in operations: from theory to practice

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Chinese NMPA approves AstraZeneca’s Calquence for leukaemia

Chinese NMPA approves AstraZeneca’s Calquence for leuka...

Sep 5, 2023

Primary care physicians are learning how to fill the gaps in gender-affirming medicine

Primary care physicians are learning how to fill the ga...

Aug 1, 2023

STAT+: Saudi VC loops Novo Nordisk, other biotech VCs into new longevity incubator

STAT+: Saudi VC loops Novo Nordisk, other biotech VCs i...

Nov 29, 2023